The sweet gatekeeper: Mucin-type O-glycans in brain endothelial glycocalyx and aging.

Duan Lu Hou, Yun-Cheng Wu, Eng King Tan, Zhi Dong Zhou

National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No.86, Wujin Road, Shanghai 200080, China. Electronic address: [email protected]. · pubmed

Paper

Abstract

The blood-brain barrier (BBB) is crucial for brain homeostasis, and its dysfunction is associated with aging and neurodegenerative diseases. A recent seminal study by Shi et al. (2025) published in Nature illuminates a previously underappreciated component, the brain endothelial glycocalyx, as a key player in age-related BBB breakdown. They demonstrated that aging and neurodegenerative disease can lead to significant structural and compositional dysregulation of the brain endothelial glycocalyx, specifically involving mucin-domain glycoproteins, which ultimately contribute significantly to BBB thinning. Restoring core 1 mucin-type O-glycans can improve BBB function, reduce neuroinflammation, and ameliorate cognitive deficits in aged mice. We contextualize these findings within the broader landscape of glycobiology, neurovascular research, and the concepts of inflammaging and immunosenescence, highlighting recent related discoveries and discussing the limitations and future challenges in translating these insights into therapeutic strategies for healthy brain aging.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Restoring core 1 mucin-type O-glycans can improve blood-brain barrier function and reduce neuroinflammation in aged mice. This paper addresses a potential root cause of aging-related brain dysfunction, focusing on the structural integrity of the blood-brain barrier, which is crucial for healthy brain aging and longevity.

Author of this paper? Send a correction.